Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Mitobridge patents

List of Mitobridge patents

List of Opex Corporation patents

List of Bragi (company) patents

List of Fastvdo Llc patents

List of SBIR/STTR awards granted to Fluxion Biosciences

List of SBIR/STTR awards granted to Smart Material Solutions, Inc.

Patents where

Current Assignee

Name

is

Mitobridge

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11358954 PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof	Patent 11358954 was granted and assigned to Mitobridge on June, 2022 by the United States Patent and Trademark Office.	Mitobridge	Mitobridge		United States Patent and Trademark Office	11358954	June 14, 2022
	‌ US Patent 10927094 Crystalline and salt forms of PPAR agonist compounds	Patent 10927094 was granted and assigned to Mitobridge on February, 2021 by the United States Patent and Trademark Office.	Mitobridge	Mitobridge		United States Patent and Trademark Office	10927094	February 23, 2021
	‌ US Patent 11530192 Crystalline and salt forms of PPAR agonist compounds	Patent 11530192 was granted and assigned to Mitobridge on December, 2022 by the United States Patent and Trademark Office.	Mitobridge	Mitobridge		United States Patent and Trademark Office	11530192	December 20, 2022
	‌ US Patent 11034670 Poly-ADP ribose polymerase (PARP) inhibitors	Patent 11034670 was granted and assigned to Mitobridge on June, 2021 by the United States Patent and Trademark Office.	Mitobridge	Mitobridge		United States Patent and Trademark Office	11034670	June 15, 2021
	‌ US Patent 10766888 HMOX1 inducers	Patent 10766888 was granted and assigned to Mitobridge on September, 2020 by the United States Patent and Trademark Office.	Mitobridge	Mitobridge		United States Patent and Trademark Office	10766888	September 8, 2020
	‌ US Patent 11168080 Dynamin-1-like protein inhibitors	Patent 11168080 was granted and assigned to Mitobridge on November, 2021 by the United States Patent and Trademark Office.	Mitobridge	Mitobridge		United States Patent and Trademark Office	11168080	November 9, 2021
	‌ US Patent 10968172 USP30 inhibitors	Patent 10968172 was granted and assigned to Mitobridge on April, 2021 by the United States Patent and Trademark Office.	Mitobridge	Mitobridge		United States Patent and Trademark Office	10968172	April 6, 2021
	‌ US Patent 10874641 Methods of treating acute kidney injury		Mitobridge	Mitobridge		United States Patent and Trademark Office	10874641	December 29, 2020
	‌ US Patent 10611790 Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases		Mitobridge	Mitobridge		United States Patent and Trademark Office	10611790	April 7, 2020
	‌ US Patent 11912681 Crystalline and salt forms of PPAR agonist compounds	Patent 11912681 was granted and assigned to Mitobridge on February, 2024 by the United States Patent and Trademark Office.	Mitobridge	Mitobridge		United States Patent and Trademark Office	11912681	February 27, 2024
	‌ US Patent 11993585 Poly-ADP ribose polymerase (PARP) inhibitors	Patent 11993585 was granted and assigned to Mitobridge on May, 2024 by the United States Patent and Trademark Office.	Mitobridge	Mitobridge		United States Patent and Trademark Office	11993585	May 28, 2024

11 results

0 selected

11 results

0 selected